What is the recommended induction dose of ketamine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ketamine Induction Dose

For anesthesia induction, administer ketamine 2 mg/kg intravenously over 60 seconds, or 9-13 mg/kg intramuscularly for adults. 1

Intravenous Dosing

The FDA-approved intravenous induction dose ranges from 1-4.5 mg/kg, with 2 mg/kg being the standard dose that produces 5-10 minutes of surgical anesthesia within 30 seconds 1. This dose is supported by multiple pediatric emergency medicine guidelines showing effective procedural sedation at 1.5-2 mg/kg IV 2.

Critical administration details:

  • Administer slowly over 60 seconds to avoid respiratory depression and enhanced vasopressor response 1
  • The 100 mg/mL concentration must be diluted 1:1 with sterile water, normal saline, or D5W before IV administration 1
  • Alternative infusion rate: 0.5 mg/kg/min 1

Intramuscular Dosing

The IM route requires 6.5-13 mg/kg, with 9-13 mg/kg producing surgical anesthesia within 3-4 minutes and lasting 12-25 minutes 1. Pediatric studies confirm 4 mg/kg IM as effective for procedural sedation 2.

Context-Specific Dosing

Procedural sedation (pediatrics): 1.5 mg/kg IV provides adequate sedation with lower need for supplemental doses compared to 1 mg/kg 2

Adjunctive perioperative use: Maximum 0.5 mg/kg bolus followed by 0.125-0.25 mg/kg/h infusion for anti-hyperalgesic effects in high-risk pain surgeries 3

Rapid sequence intubation: Standard 1-2 mg/kg IV is appropriate; doses >2 mg/kg are associated with significantly increased adverse events including hypotension (OR 7.0), laryngospasm (OR 10.8), and bradycardia (OR 7.5) 4

Important Safety Considerations

Contraindications: Avoid in patients with ischemic heart disease, cerebrovascular disease, or uncontrolled hypertension due to dose-dependent increases in heart rate, blood pressure, and cardiac output 5

Emergence reactions: Occur in 10-30% of adults, manifesting as hallucinations, vivid dreams, and delirium 5, 6. Co-administer a benzodiazepine to minimize this risk 1

Antisialagogue: Administer prior to induction due to potential for excessive salivation 1

Airway management: While laryngeal-pharyngeal reflexes may be preserved, vomiting and aspiration can occur. Emergency airway equipment must be immediately available, and continuous vital sign monitoring is mandatory 1

The evidence consistently supports 2 mg/kg IV as the optimal balance between efficacy and safety for anesthesia induction, with higher doses increasing adverse event risk without proportional benefit 4. Lower doses (1-1.5 mg/kg) may be adequate for procedural sedation but often require supplementation 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.